Skip to main content
Figure 4 | Molecular Cancer

Figure 4

From: Effects of nilotinib on regulatory T cells: the dose matters

Figure 4

Nilotinib inhibits the cytokine production by CD4+CD25+ T cells and CD4+CD25- T cells. Panel A: CD4+CD25+ T cells were stimulated with anti-CD3, anti-CD28 and IL-2 in the presence or absence of 25 μM nilotinib. After 4 days incubation, supernatants were collected for cytokine analysis. The high intensity spots in the three corners are positive controls, the lower right contains the negative controls. Panel B: Graphs of the relative density (subtracted the average background signals) are shown for selected cytokines. Array images are shown in panel A and profiles created by quantifying the background-subtracted mean spot pixel densities are identified as shown in Panel B by using image analysis software. Panel C + D: The cytokine production of CD4+CD25- T cells treated with nilotinib was analyzed by above methods.

Back to article page